ArticleRSC advances2025
Palladium nanoparticles from β-cyclodextrin and cellulose methyl carboxylate as an effective catalyst for Sonogashira coupling and the reduction of alkynes.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fucoidan-mediated green synthesis of palladium nanoparticles as a recyclable catalyst for Heck coupling and alkyne reduction in pheromone synthesis.RSC advances · 2025Article
- Photochemical synthesis of Pd nanocatalysts stabilized by biomass-derived polymers: from colloidal to supported systems in batch and flow.RSC advances · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This research presents an effective approach for synthesizing palladium nanoparticle (PdNP) catalysts, employing β-cyclodextrin (β-CD) as a reducing agent and cellulose methyl carboxylate (CMC) as a stabilizer. PdNP-based nanocomposites were prepared by varying the mass ratios of CMC to β-CD from 1 : 1 to 3 : 2. Their structural and physicochemical properties were thoroughly analyzed using multiple characterization techniques, including ultraviolet-visible spectroscopy (UV-vis), FTIR, DLS, Zeta potential, XRD, TGA, and TEM. The resulting PdNPs exhibited a crystalline structure with particle dimensions spanning from 2 to 10 nm, with the majority falling between 4 and 6 nm. These nanoparticles demonstrated outstanding catalytic activity in Sonogashira coupling reactions, operating without additional catalysts and efficiently converting alkynes into (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.